Virbac RILEXINE (cephalexin) is a broad-spectrum cephalosporin indicated for the treatment of bacterial infections in dogs and cats.

INDICATIONS

• • Bacterial Skin Infections (Pyoderma): The primary, FDA-approved indication is the treatment of secondary superficial bacterial pyoderma caused by susceptible strains of Staphylococcus pseudintermedius. It is also widely licensed internationally for deep pyodermas.
  • Urinary Tract Infections (UTIs): Used to treat infections of the urinary tract, including cystitis (bladder inflammation) and nephritis (kidney inflammation) caused by susceptible organisms.
  • Respiratory and Digestive Infections: Depending on regional veterinary registrations, it can be indicated for treating susceptible infections of the respiratory and digestive systems.

• Skin and Subcutaneous Infections: Indicated for treating cutaneous and subcutaneous bacterial infections, such as infected wounds and abscesses.
• Urinary Tract Infections (UTIs): Licensed internationally for treating feline cystitis and nephritis.

ADMINISTRATION

• Administration: Tablets are generally given orally twice a day. The chewable formulations are designed for high palatability to ensure your pet actually consumes the full dose.
• Contraindications: Do not use in animals with a known allergy or hypersensitivity to cephalexin, penicillins, or any other beta-lactam antibiotics.
• Possible Side Effects: The most common adverse reactions include vomiting, diarrhea, anorexia, and lethargy.